FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

28401011000001108: Biquelle XL 200mg tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jan 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
89289401000001114 Biquelle XL 200mg tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
89289501000001113 Biquelle XL 200mg tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Is a Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each prolonged-release oral tablet true Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has active ingredient Quetiapine false Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has manufactured dose form Extended-release tablet false Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has specific active ingredient Quetiapine fumarate true Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Quetiapine true Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Is a Biquelle XL true Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has basis of strength substance Quetiapine true Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has manufactured dose form Prolonged-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Biquelle XL 200mg tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Has AMP True Biquelle XL 200mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Has AMP True Biquelle XL 200mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start